Today: 19 July 2026
TE Connectivity stock price holds near $241 as TEL heads into Jan. 21 earnings
19 January 2026
1 min read

TE Connectivity stock price holds near $241 as TEL heads into Jan. 21 earnings

New York, Jan 18, 2026, 18:37 EST — Market closed.

  • TE Connectivity (TEL) ended at $241.01, slipping 0.38%.
  • U.S. stock markets remain closed Monday in observance of Martin Luther King Jr. Day; trading picks back up Tuesday.
  • TE will release its fiscal first-quarter results before the market opens on Wednesday, Jan. 21.

TE Connectivity plc heads into the holiday-shortened week with earnings set for Jan. 21, following a slight dip on Friday. The stock closed at $241.01, down 0.38%, after fluctuating between $239.96 and $242.99.

Why it matters now: with U.S. cash markets closed on Monday, there’s less time for price discovery, and the next major catalyst is just around the corner. For investors, TE’s report offers an early glimpse into demand for components used in cars, factory equipment, and network hardware.

TEL has hovered close to its highs, making the stock sensitive to more than just quarterly results — the company’s guidance matters too. Even a solid beat might be overlooked, while a cautious outlook tends to weigh on sentiment.

The New York Stock Exchange and Nasdaq will both shut down Monday in observance of Martin Luther King Jr. Day, reopening their doors Tuesday.

TE plans to announce its fiscal first-quarter results ahead of the market open on Wednesday, Jan. 21. A conference call is scheduled for 8:30 a.m. ET.

Friday saw a quiet session for U.S. stocks. The S&P 500 edged down 0.06%, while the Dow dipped 0.17%, according to MarketWatch data.

Barchart data reveals an average earnings-per-share estimate of $2.54 for the quarter, drawn from five forecasts. The company’s market value sits near $71 billion, with a forward price-to-earnings ratio of about 23 — reflecting what investors are willing to pay for anticipated profits.

TE describes itself as a producer of connectivity and sensing equipment that transfers data, power, and signals across systems—from electric vehicles to factories and communications networks, including AI hardware. Investors will be paying close attention to any changes in commentary on data-center demand and automotive sectors, where volumes tend to shift rapidly.

TE posted record quarterly sales in October, hitting $4.75 billion with adjusted earnings of $2.44 per share. It set its sights on roughly $4.5 billion in sales and adjusted EPS near $2.53 for the first quarter. CEO Terrence Curtin highlighted “strong order levels” as the new fiscal year kicks off. TE Connectivity

Connector peer Amphenol ticked up 0.11% on Friday. TE dropped 0.38%, putting TEL just behind its close competitor as attention turns to the week ahead.

However, the setup works both ways. Any slip in orders, a weaker outlook on industrial spending, or signs of margin pressure could weigh more heavily on the stock now that it’s sitting close to a 52-week peak.

Tuesday’s restart after the holiday is the next key moment, followed by TE’s report before the open on Jan. 21. The 8:30 a.m. call will be critical, with guidance expected to carry the weight.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • U.S. Bio Stocks Climb on M&A Momentum, Korean Bio Shares Drop Back
    July 19, 2026, 5:29 PM EDT. U.S. bio stocks rise further, fueled by active mergers and acquisitions and gains in biotech ETFs, as Korean bio stocks see steep declines. The KOSDAQ 150 Biotech index slid 20.63% in the last month, while bio ETFs such as UNICORN K BioActive lost 19.56%. In the U.S., the Nasdaq Biotech Index is approaching a 52-week high, and U.S.-focused ETFs like KODEX US S&P Bio added 13.62%. The relationship between Korean and U.S. bio indices has shifted, with the correlation moving from positive (0.55) to negative (-0.63). Driving the divergence are robust U.S. biotech M&A deals and sales cycles, while Korean bio names lag as funds turn toward major semiconductor stocks and broader market performance remains weak.
ICBC A-share price in focus: China’s margin clamp and PBOC signals set up Monday’s open
Previous Story

ICBC A-share price in focus: China’s margin clamp and PBOC signals set up Monday’s open

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Next Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

Go toTop